Table 2.
Relevant physical characteristics of principal emergent therapeutic radionuclides [8].
| Radionuclide | Half-Life | Energy (keV) | Production Methods |
|---|---|---|---|
| 67Cu | 2.58 d | Eβ−mean = 141 Eγ = 91; 93; 185 |
68Zn(p,2p)67Cu 68Zn(γ,p)67Cu 70Zn(p,α)67Cu 70Zn(d,αn)67Cu |
| 47Sc | 3.35 d | Eβ−mean = 162 Eγ = 159 |
47Ti(n,p)47Sc 46Ca(n,γ)47Ca → 47Sc 48Ca(γ,n)47Ca → 47Sc |
| 166Ho | 26.82 h | Eβ−mean = 665 Eγ = 81 |
165Ho(n,γ)166Ho 164Dy(2n,γ)166Dy → 166Ho |
| 161Tb | 6.89 d | Eβ−mean = 154 Eγ =49; 75 |
160Gd(n,γ)161Gd → 161Tb |
| 212Pb (212Bi) | 10.64 h (60.6 min) | Eβ−mean = 100 Eγ = 238; 300 (Eα = 6050; 6089) |
224Ra/212Pb generator |
| 225Ac | 10.0 d | Eα = From 5637 to 5830 Eγ =99.8 |
232Th(p,2p6n)225Ac 226Ra(p,2n)225Ac 226Ra(γ,n)225Ra → 225Ac |
| 213Bi | 45.6 min | Eα = 5558; 5875 Eγ = 324 |
225Ac/213Bi generator |
| 223Ra | 11.4d | Eα = From 5433 to 5871 Eγ = 144; 154; 269; 324; 338 |
227Ac/227Th/223Ra gen. |